Back

Early relevant alerts from remote monitoring in heart failure patients with a cardiac implanted electronic device: what implications for long term outcome?

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: ICD and remote monitoring Home and Remote Patient Monitoring EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Davide Antonio Mei

Modena Polyclinic Modena University Hospital, Modena (Italy)

5 More presentations in this session

Presentation thumbnail
Feasibility of left bundle branch area defibrillator implantation using three-dimensional delivery systems and traditional high voltage leads
Doctor C. Mandurino (Taranto, IT)
Abstract Slides Video
Presentation thumbnail
Sex differences among S-ICD recipients: a propensity-matched, multicenter, international analysis from the i-SUSI project
Doctor M. Schiavone (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Enhancing heart failure management: a comprehensive analysis of continuous remote monitoring vs. standard care in patients with cardiac implantable electronic devices
Doctor B. Veres (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Long-term prognostic role of pre-ICD implantation magnetic resonance: a longitudinal cohort study
Doctor M. Spoladori (Parma, IT)
Abstract Slides Video
Presentation thumbnail
Substernal lead removal: experience from the EV ICD pivotal study
Doctor A. Amin (Columbus, US)
Abstract Slides Video

Access the full session

Session thumbnail
ICD and remote monitoring
Video

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Session
Alert-based remote monitoring: changing the paradigm of CIED follow-up
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Congress Presentation
Assessing adherence to remote monitoring recommendations for cardiovascular implantable electronic devices: a retrospective analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources